1. Pulmonary fibrosis from molecular mechanisms to therapeutic interventions: lessons from post-COVID-19 patients
   Chiara Giacomelli et al, 2021, Biochemical Pharmacology CrossRef
2. Dual drug delivery collagen vehicles for modulation of skin fibrosis in vitro
   João Q Coentro et al, 2022, Biomed. Mater. CrossRef
3. THE TRANSLATIONAL POSSIBILITY OF TARGETING LncRNAs AS A THERAPEUTIC STRATEGY FOR IDIOPATHIC PULMONARY FIBROSIS
   RAKESH KUMAR YADAV et al, 2022, Asian J Pharm Clin Res CrossRef
4. Mammalian Neuraminidases in Immune-Mediated Diseases: Mucins and Beyond
   Erik P. Lillehoj et al, 2022, Front. Immunol. CrossRef
5. Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis
   Manas Sehgal et al, 2022, Heliyon CrossRef
6. Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
   Daniela Oatis et al, 2022, IJMS CrossRef
7. Virtual screening and activity evaluation of multitargeting inhibitors for idiopathic pulmonary fibrosis
   Rui Wang et al, 2022, Front. Pharmacol. CrossRef
8. New insights into methylome alterations and consequences during myofibroblastic differentiation in pulmonary fibrosis
   Arnaud A. Mailleux et al, 2022, Eur Respir J CrossRef
9. BMP3b Is a Novel Antifibrotic Molecule Regulated by Meflin in Lung Fibroblasts.
   Atsushi Suzuki et al, 2022, Am J Respir Cell Mol Biol CrossRef
10. Evaluation of Sirtuin 1 Levels in Peripheral Blood Mononuclear Cells of Patients With Idiopathic Pulmonary Fibrosis.
    Konstantina Deskata et al, 2022, Cureus CrossRef
11. Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway
    Yang Miao et al, 2022, International Immunopharmacology CrossRef
12. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities
    Li-Li Ren et al, 2022, Chemico-Biological Interactions CrossRef
13. TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis
    Huifang Chen et al, 2021, Cell Death Dis CrossRef
14. The role of autophagy in idiopathic pulmonary fibrosis: from mechanisms to therapies
    Yue-Liang Yue et al, 2022, Ther Adv Respir Dis CrossRef
15. Plant miRNA osa-miR172d-5p suppressed lung fibrosis by targeting Tab1
    Motofumi Kumazoe et al, 2023, Sci Rep CrossRef
16. The Therapeutic Mechanism of Schisandrol A and Its Metabolites on Pulmonary Fibrosis Based on Plasma Metabonomics and Network Analysis
    Xijier Qiaolongbatu et al, 2023, DDDT CrossRef
17. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway
    Guirong Li et al, 2023, Lung CrossRef
18. Sparganii Rhizoma alleviates pulmonary fibrosis by inhibiting fibroblasts differentiation and epithelial-mesenchymal transition mediated by TGF-β1/ Smad2/3 pathway
    Jing Liu et al, 2023, Journal of Ethnopharmacology CrossRef
19. Targeting TGF-β/periostin signaling by sesamol ameliorates pulmonary fibrosis and improves lung function and survival
    Satya Krishna Tirunavalli et al, 2023, The Journal of Nutritional Biochemistry CrossRef
20. Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
    Nikitha Naomi Dsouza et al, 2023, Inflammopharmacol CrossRef
21. Repurposing of carvedilol to alleviate lung fibrosis in rats: Repressing of TGF-β1/α-SMA/Smad2/3 and STAT3 gene expressions
    Noha A.T. Abbas et al, 2023, Life Sciences CrossRef
22. null
    Avanka Gunatilaka et al, 2023 CrossRef
23. PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo
    Hu-Nan Sun et al, 2023, Cell Mol Biol Lett CrossRef
24. Effect of FTY-720 on Pulmonary Fibrosis in Mice via the TGF-β1 Signaling Pathway and Autophagy
    Yuying Jin et al, 2023, Biomol Ther (Seoul) CrossRef
25. Polymer-Functionalized Mitochondrial Transplantation to Fibroblasts Counteracts a Pro-Fibrotic Phenotype
    Gherardo Baudo et al, 2023, IJMS CrossRef
26. Atractylodin Ameliorates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice
    Zhenhui Wu et al, 2023, Pharmacological Research - Modern Chinese Medicine CrossRef
27. Diagnostic and therapeutic potential of transforming growth factor beta 1 in solid organ transplantation: recent research findings
    S. O. Sharapchenko et al, 2023, RJTAO CrossRef
28. Neotuberostemonine and tuberostemonine ameliorate pulmonary fibrosis through suppressing TGF-β and SDF-1 secreted by macrophages and fibroblasts via the PI3K-dependent AKT and ERK pathways
    San FU et al, 2023, Chinese Journal of Natural Medicines CrossRef
29. Epithelial–Mesenchymal Transition Mechanisms in Chronic Airway Diseases: A Common Process to Target?
    Angélique Mottais et al, 2023, IJMS CrossRef
30. Flavokawain A ameliorates pulmonary fibrosis by inhibiting the TGF-β signaling pathway and CXCL12/CXCR4 axis
    Ting Xiao et al, 2023, European Journal of Pharmacology CrossRef
31. On the path to predicting immune responses in the lung: Modeling the pulmonary innate immune system at the air-liquid interface (ALI)
    Jodi Graf et al, 2023, European Journal of Pharmaceutical Sciences CrossRef
32. The novel peptide DR4penA attenuates the bleomycin‐ and paraquat‐induced pulmonary fibrosis by suppressing the TGF‐β/Smad signaling pathway
    Dan Wang et al, 2023, The FASEB Journal CrossRef
33. The main bioactive compound of Panax notoginseng, notoginsenoside R1, alleviates pulmonary fibrosis via MBD2/SHIP and STAT3 pathway
    Juan Wang et al, 2023, Journal of Functional Foods CrossRef
34. Protein lysine acetylation played an important role in NH3-induced AEC2 damage and pulmonary fibrosis in piglets
    Xiaotong Wang et al, 2024, Science of The Total Environment CrossRef
35. Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
    Qian Zeng et al, 2023, Sci Rep CrossRef
36. Integrated bioinformatics analysis for the identification of idiopathic pulmonary fibrosis–related genes and potential therapeutic drugs
    Zhenzhen Zhang et al, 2023, BMC Pulm Med CrossRef
37. Opposing roles for TGFβ- and BMP-signaling during nascent alveolar differentiation in the developing human lung
    Tristan Frum et al, 2023, npj Regen Med CrossRef
38. Epithelial-fibroblast interactions in IPF: Lessons from in vitro co-culture studies
    J. Brussow et al, 2023, Differentiation CrossRef
39. Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues
    Shobhit Gairola et al, 2023, Inflammopharmacol CrossRef
40. Investigating rutin as a potential transforming growth factor‐β type I receptor antagonist for the inhibition of bleomycin‐induced lung fibrosis
    Wisurumuni Arachchilage Hasitha Maduranga Karunarathne et al, 2023, BioFactors CrossRef
41. Deciphering the age-dependent changes of pulmonary fibroblasts in mice by single-cell transcriptomics
    Rundong Wu et al, 2023, Front. Cell Dev. Biol. CrossRef
42. LncRNA SNHG8 upregulates MUC5B to induce idiopathic pulmonary fibrosis progression by targeting miR-4701-5p
    Xiaoping Zhang et al, 2023, Heliyon CrossRef
43. The Influence of Betulin Derivatives EB5 and ECH147 on the Expression of Selected TGFβ Superfamily Genes, TGFβ1, GDF15 and BMP2, in Renal Proximal Tubule Epithelial Cells
    Sebastian Kubica et al, 2023, CIMB CrossRef
44. Therapeutic strategies to target connective tissue growth factor in fibrotic lung diseases
    Takuma Isshiki et al, 2023, Pharmacology & Therapeutics CrossRef
45. Club Cells—A Guardian against Occupational Hazards
    Marina Ruxandra Otelea et al, 2023, Biomedicines CrossRef
46. Platycodin D ameliorates ammonia‐induced pulmonary fibrosis by repressing TGF‐β1‐mediated extracellular matrix remodeling
    Wenqi Lian et al, 2024, Chem Biol Drug Des CrossRef
47. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Tom Voisin et al, 2024, The Journal of Nutritional Biochemistry CrossRef
48. Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis
    Zeqi Wu et al, 2024, Phytomedicine CrossRef
49. Epigenetic mechanisms of particulate matter exposure: air pollution and hazards on human health
    Dulcemaría Gavito-Covarrubias et al, 2024, Front. Genet. CrossRef
50. Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways
    Wenxin Luo et al, 2023, European Journal of Medicinal Chemistry CrossRef
51. Antifibrotic Drugs against Idiopathic Pulmonary Fibrosis and Pulmonary Fibrosis Induced by COVID-19: Therapeutic Approaches and Potential Diagnostic Biomarkers
    Aurelio Perez-Favila et al, 2024, IJMS CrossRef
52. HSP70 Is a Critical Regulator of HSP90 Inhibitor’s Effectiveness in Preventing HCl-Induced Chronic Lung Injury and Pulmonary Fibrosis
    Ruben M. L. Colunga Biancatelli et al, 2024, IJMS CrossRef
53. TGF-β1, pSmad-2/3, Smad-7, and β-Catenin Are Augmented in the Pulmonary Arteries from Patients with Idiopathic Pulmonary Fibrosis (IPF): Role in Driving Endothelial-to-Mesenchymal Transition (EndMT)
    Archana Vijay Gaikwad et al, 2024, JCM CrossRef
54. Summary of Experience in Using Professor Chao Enxiang’s Shenjing Wuwei Recipe to Treat Interstitial Pulmonary Fibrosis
    伟斌 吴, 2024, TCM CrossRef
55. Qingkailing granule alleviates pulmonary fibrosis by inhibiting PI3K/AKT and SRC/STAT3 signaling pathways
    Hong Li et al, 2024, Bioorganic Chemistry CrossRef
56. Current and Novel Treatment Modalities of Idiopathic Pulmonary Fibrosis
    Mahnoor Arshad et al, 2024 CrossRef
57. Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice
    Kaveri R. Washimkar et al, 2023, Life Sciences CrossRef
58. Trillin Protects Against Bleomycin-Induced Pulmonary Fibrosis via Suppressing Oxidative Stress and IL-1β/NLRP3 Inflammasome Positive Cycle
    Xiangyun Li et al, 2024, Natural Product Communications CrossRef
59. İklim Değişikliğinin Vektörel Hastalıklara Etkisi ve Kırım Kongo Kanamalı Ateşi Hastalığı
    Fatih DÖKMEDEMİR et al, 2023 CrossRef
60. Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats
    Arian Amirkhosravi et al, 2024, Sci Rep CrossRef
61. Pulmonary fibrosis after a new coronavirus infection – versions and controversies: A review
    Evgeny I. Shchepikhin et al, 2024, Terapevticheskii arkhiv CrossRef
62. lncRNA-mRNA Co-Expression and Regulation Analysis in Lung Fibroblasts from Idiopathic Pulmonary Fibrosis
    Armando López-Martínez et al, 2024, ncRNA CrossRef
63. The future of chemical pleurodesis: A review of novel and investigational sclerosant agents
    Jonathan Glatt et al, 2024, The American Journal of the Medical Sciences CrossRef
64. Simvastatin attenuates silica-induced pulmonary inflammation and fibrosis in rats via the AMPK-NOX pathway
    Cunxiang Bo et al, 2024, BMC Pulm Med CrossRef
65. Vinpocetine alleviated alveolar epithelial cells injury in experimental pulmonary fibrosis by targeting PPAR-γ/NLRP3/NF-κB and TGF-β1/Smad2/3 pathways
    Zeena A. Hussein et al, 2024, Sci Rep CrossRef
66. The mysterious association between adiponectin and endometriosis
    Yong-Qing Zhao et al, 2024, Front. Pharmacol. CrossRef
67. Glycyrrhetinic acid loaded in milk-derived extracellular vesicles for inhalation therapy of idiopathic pulmonary fibrosis
    Bo Ran et al, 2024, Journal of Controlled Release CrossRef
68. Vistusertib improves pulmonary inflammation and fibrosis by modulating inflammatory/oxidative stress mediators via suppressing the mTOR signalling
    Taslim B. Shaikh et al, 2024, Inflamm. Res. CrossRef
69. Influence of intersignaling crosstalk on the intracellular localization of YAP/TAZ in lung cells
    I. A. Govorova et al, 2024, Cell Commun Signal CrossRef
70. Fibroblast senescence-associated extracellular matrix promotes heterogeneous lung niche
    Andrew M. Howes et al, 2024 CrossRef
71. Macrophages and pulmonary fibrosis: a bibliometric and visual analysis of publications from 1990 to 2023
    Yi Min et al, 2024, Front. Med. CrossRef
72. Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis
    Yang Zhou et al, 2024, Respir Res CrossRef
73. Stem cell-based therapy for fibrotic diseases: mechanisms and pathways
    Marjan Taherian et al, 2024, Stem Cell Res Ther CrossRef
74. Therapeutic potential of human stem cell-derived extracellular vesicles in idiopathic pulmonary fibrosis
    Kyoung Soo Lee et al, 2024, Extracellular Vesicle CrossRef
75. Mapping spatially resolved transcriptomes in human and mouse pulmonary fibrosis
    Lovisa Franzén et al, 2024, Nat Genet CrossRef
76. Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
    Zezhou Shi et al, 2024, Archiv der Pharmazie CrossRef
77. Interstitial Lung Diseases and Non-Small Cell Lung Cancer: Particularities in Pathogenesis and Expression of Driver Mutations
    Fotios Sampsonas et al, 2024, Genes CrossRef
78. CD206+macrophages are relevant non-invasive imaging biomarkers and therapeutic targets in experimental lung fibrosis
    Lenny Pommerolle et al, 2024, Thorax CrossRef
79. The role of fibrosis in endometriosis: a systematic review
    Guus Vissers et al, 2024 CrossRef
80. Cellular and Molecular Genetic Mechanisms of Lung Fibrosis Development and the Role of Vitamin D: A Review
    Darya Enzel et al, 2024, IJMS CrossRef
81. Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1A
    Tong Zhao et al, 2024, Acta Pharmacol Sin CrossRef
82. Idiopathic Pulmonary Fibrosis: Review of Current Knowledge
    J Muri et al, 2024, Physiol Res CrossRef
83. Gene-level alignment of single-cell trajectories
    Dinithi Sumanaweera et al, 2024, Nat Methods CrossRef
84. Iron-laden macrophage-mediated paracrine profibrotic signaling induces lung fibroblast activation
    Yunqi Li et al, 2024, American Journal of Physiology-Cell Physiology CrossRef
85. Quantitative proteomics reveals the mechanism of endoplasmic reticulum stress-mediated pulmonary fibrosis in mice
    Heng Li et al, 2024, Heliyon CrossRef
86. Gene expression profile analysis of severe influenza-based modulation of idiopathic pulmonary fibrosis
    Jianping Kong et al, 2024, Eur J Med Res CrossRef
87. Endoplasmic reticulum stress induces renal fibrosis in high‑fat diet mice via the TGF‑β/SMAD pathway
    Zhidan Mu et al, 2024, Mol Med Rep CrossRef
88. Development of a multi-analysis model using an epithelial-fibroblast co-culture system as an alternative to animal testing
    Min-Ju Kim et al, 2024, Environ Anal Health Toxicol CrossRef
89. Integrated multiomic analysis identifies TRIP13 as a mediator of alveolar epithelial type II cell dysfunction in idiopathic pulmonary fibrosis
    Laurence St. Pierre et al, 2024, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
90. Allium sativum nanovesicles exhibit anti-inflammatory and antifibrotic activity in a bleomycin-induced lung fibrosis model
    Jovito Cesar Santos-Álvarez et al, 2024, Mol Biol Rep CrossRef
91. Bruceine A inhibits TGF-β1/Smad pathway in pulmonary fibrosis by blocking gal3/TGF-β1 interaction
    Chao Du et al, 2024, Phytomedicine CrossRef
92. Co-culture of human AT2 cells with fibroblasts reveals a MUC5B phenotype: insights from an organoid model
    Yiwen Yao et al, 2024, Mol Med CrossRef
93. Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review
    Marisa Denisse Colin Waldo et al, 2024, CIMB CrossRef
94. Chamomile flowers extract protects against thinner inhalation-induced lung toxicity via attenuating cytochrome P2E1 activity, surfactant deficiency, and alveolar structural injury in rats
    Azza M. Elgharieb et al, 2024, Beni-Suef Univ J Basic Appl Sci CrossRef
95. The Role of TRP Channels in Lung Fibrosis: Mechanisms and Therapeutic Potential
    M Ratnasingham et al, 2024, The International Journal of Biochemistry & Cell Biology CrossRef
96. Effect of CTMP1 gene on pulmonary fibrosis
    Huonggiang Nguyen et al, 2024, Toxicol Res. CrossRef
97. Transforming growth factor-beta is increased in sputum from individuals with rheumatoid arthritis-associated pulmonary fibrosis
    Timothy M Wilson et al, 2024 CrossRef
98. Dopamine Receptor D1 Is Exempt from Transforming Growth Factor β-Mediated Antifibrotic G Protein-Coupled Receptor Landscape Tampering in Lung Fibroblasts
    Ashley Y. Gao et al, 2023, The Journal of Pharmacology and Experimental Therapeutics CrossRef
99. hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1
    Yanyang Wang et al, 2025, Stem Cell Res Ther CrossRef